Latest News and Press Releases

CERTARA APPOINTS DR. ADRIAN MCKEMEY AS PRESIDENT OF DRUG DEVELOPMENT SOLUTIONS

NEWARK, Del, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The global peptone market is projected to grow steadily, with sales estimated at USD 846.4 million in 2024 and expected to reach USD 1,299.0 million by...

Certara today announced the appointment of John Reynders, PhD to its Board of Directors, effective October 15, 2024.

Certara completes acquiring Chemaxon, a leading cheminformatics company that develops scientific informatics software used by the life sciences industry.

Certara shared the results from its collaboration with Ichnos Glenmark Innovation (IGI) on the first-in-human dose prediction and selection for ISB 2001.

Certara today announced the launch of Phoenix™ version 8.5 software, the pharmaceutical industry's gold standard in PK/PD modeling and simulation.

Certara has signed a definitive agreement to acquire Chemaxon, a leading provider of cheminformatics software.

Certara today unveiled its next-generation CoAuthor regulatory writing software. CoAuthor is an advanced writing platform designed for medical writers.

NEWARK, Del, April 23, 2024 (GLOBE NEWSWIRE) -- The mammalian cell fermentation technology market is estimated to be worth US$ 45.9 billion in 2024 and is projected to be valued at US$ 68 billion by...

Combined Certara-Applied Biomath organization establishes the life sciences industry’s largest quantitative systems pharmacology center.